Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated π-Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma Cells
Open Access
- 1 June 2002
- journal article
- Published by Elsevier
- Vol. 277 (25) , 22573-22580
- https://doi.org/10.1074/jbc.m203009200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Genetic Instability and Aberrant Dna Methylation in Chronic Hepatitis and Cirrhosis—A Comprehensive Study of Loss of Heterozygosity and Microsatellite Instability At 39 Loci and Dna Hypermethylation on 8 Cpg Islands in Microdissected Specimens From Patients With Hepatocellular CarcinomaHepatology, 2000
- DNA methylation: past, present and future directionsCarcinogenesis: Integrative Cancer Research, 2000
- Dna Hypermethylation At the D17s5 Locus and Reduced Hic–1 Mrna Expression Are Associated With HepatocarcinogenesisHepatology, 1999
- Human DNA-(Cytosine-5) Methyltransferase-PCNA Complex as a Target for p21 WAF1Science, 1997
- The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomasInternational Journal of Cancer, 1997
- Aberrant DNA Methylation on Chromosome 16 Is an Early Event in HepatocarcinogenesisJapanese Journal of Cancer Research, 1996
- Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2Nucleic Acids Research, 1993
- A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nucleiPublished by Elsevier ,1992
- Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNANucleic Acids Research, 1992
- Isolation and characterization of the cDNA encoding human DNA methyltransferaseNucleic Acids Research, 1992